Loading...
Caritas Healthcare Private Limited — Fluorouracil Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #14 for Fluorouracil · $99.0K export value · DGFT Verified
Caritas Healthcare Private Limited is the #14 Indian exporter of Fluorouracil with $99.0K in export value and 6 verified shipments. Caritas Healthcare Private Limited holds a 0.8% market share in Fluorouracil exports across 1 countries. The company exports 9 pharmaceutical products worth $7.2M across 6 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $6.1M | 136 | 59.4% |
| COLOMBIA | $836.4K | 47 | 8.2% |
| MOROCCO | $510.0K | 38 | 5.0% |
| THAILAND | $430.8K | 19 | 4.2% |
| NETHERLANDS | $416.6K | 35 | 4.1% |
| SPAIN | $334.0K | 15 | 3.3% |
| FRANCE | $300.0K | 6 | 2.9% |
| ECUADOR | $223.2K | 19 | 2.2% |
| CHILE | $217.9K | 18 | 2.1% |
| UNITED KINGDOM | $183.9K | 25 | 1.8% |
India exports Fluorouracil to 130 countries. The top destination is UNITED STATES (59.4%), followed by COLOMBIA and MOROCCO.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| J. KNIPPER & COMPANY | UNITED STATES | $1.0M | 20 |
| XIROMED LLC | UNITED STATES | $999.8K | 24 |
| EVERSANA LIFE SCIENCES SERVICES,LLC | UNITED STATES | $900.0K | 18 |
| J KNIPPER COMPANY | UNITED STATES | $700.0K | 14 |
| XXCORXXHEAXXHCAXX B XX | FRANCE |
India exported $10.1M worth of Fluorouracil through 2,093 shipments from 231 suppliers to 130 countries, serving 473 buyers globally. Caritas Healthcare Private Limited contributes $99.0K to this total, accounting for 0.8% of India's Fluorouracil exports.
Caritas Healthcare Private Limited's average Fluorouracil shipment value is $16.5K per consignment, based on 6 shipments totaling $99.0K.
Caritas Healthcare Private Limited ranks #14 among 231 Indian Fluorouracil exporters with a 0.8% market share. The top 3 exporters are INTAS PHARMACEUTICALS LIMITED ($3.2M), ALEMBIC PHARMACEUTICALS LIMITED ($1.9M), NAPROD LIFE SCIENCES PRIVATE LIMITED ($1.7M). Caritas Healthcare Private Limited processed 6 shipments to 1 destination countries.
What Caritas Healthcare Private Limited must comply with to export Fluorouracil to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #14 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | OPES HEALTH CARE PRIVATE LIMITED | $124.2K | 13 | 1 | $9.6K |
| 13 | CAPLIN POINT LABORATORIES LIMITED | $120.7K | 12 | 3 | $10.1K |
| 14 | CARITAS HEALTHCARE PRIVATE LIMITED ★ | $99.0K | 6 | 1 | $16.5K |
| 15 | GETWELL PHARMACEUTICALS | $83.2K | 79 |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 384 | 18.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 354 | 16.9% |
| DELHI AIR CARGO ACC (INDEL4) | 345 | 16.5% |
| DELHI AIR | 226 | 10.8% |
| Bombay Air | 103 | 4.9% |
| AHEMDABAD AIR ACC (INAMD4) | 61 | 2.9% |
| NHAVA SHEVA SEA (INNSA1) | 61 | 2.9% |
| Delhi Air | 57 | 2.7% |
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Caritas Healthcare. The Israel-Iran conflict has disrupted Middle East trade routes, leading to increased shipping costs and logistical complexities. Reports indicate that maritime carriers have suspended bookings for sailings into the Persian Gulf, and vessels are being diverted around the Cape of Good Hope, extending transit times and escalating freight charges. (pharmaceuticalcommerce.com) These disruptions necessitate strategic adjustments in shipment schedules and inventory management to mitigate potential losses.
Conversely, the India–European Union Free Trade Agreement, concluded on January 27, 2026, is poised to eliminate tariffs on pharmaceuticals, enhancing market access for Indian exporters. (en.wikipedia.org) This development offers Caritas Healthcare an opportunity to strengthen its presence in the European market, capitalizing on reduced trade barriers and increased competitiveness.
India's pharmaceutical industry has made significant strides in regulatory compliance, with the country surpassing the United States in the number of FDA-registered generic manufacturing sites as of 2024. (business-standard.com) This achievement reflects a concerted effort to adhere to stringent international quality standards. For Caritas Healthcare, maintaining compliance with FDA, WHO GMP, and EU regulations is imperative to sustain and expand its export operations. Continuous investment in quality assurance and regulatory adherence will be crucial in navigating the evolving global pharmaceutical landscape.
Caritas Healthcare Private Limited exports 9 products worth $7.2M. Beyond Fluorouracil, top products include Tacrolimus, Carvedilol, Methylprednisolone, Rivaroxaban, Amphotericin. View the complete Caritas Healthcare Private Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Fluorouracil — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Caritas Healthcare Private Limited's Fluorouracil exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Caritas Healthcare Private Limited
Full Company Profile →
9 products · $7.2M total trade · 6 categories
| $367.6K |
| 10 |
| CPC "BIOCON" LLC | UKRAINE | $350.0K | 7 |
| ROPSOHN THERAPEUTICS SAS | COLOMBIA | $256.6K | 15 |
| J.KNIPPER & COMPANY | UNITED STATES | $250.0K | 5 |
| XXCORXXHEAXXHCAXX SXX | SPAIN | $200.0K | 4 |
| EVERSANA LIFE SCIENCES SERVICES LLC | UNITED STATES | $150.0K | 3 |
India's Fluorouracil is purchased by 473 buyers worldwide. The top buyer is J. KNIPPER & COMPANY (UNITED STATES), followed by XIROMED LLC and EVERSANA LIFE SCIENCES SERVICES,LLC.
| 9 |
| $1.1K |
Caritas Healthcare Private Limited ranks #14 among 231 Indian Fluorouracil exporters. Average shipment value of $16.5K compared to the market average of $43.9K. The closest competitors by value are OPES HEALTH CARE PRIVATE LIMITED and CAPLIN POINT LABORATORIES LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 130+ countries, 473+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Caritas Healthcare Private Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fluorouracil. For current shipment-level data, contact TransData Nexus.